Pipeline
Reglagene is Transforming Tubulin Therapies for CNS Diseases by discovering and developing novel therapies
RGN6024 - Anti-Cancer
Microtubule Targeting Agent
RGN6024 is a potent, orally administered, blood-brain barrier penetrant therapy that has been optimized for the treatment of high-grade gliomas, such as glioblastoma as well as brain metastases from breast, lung, and melanoma cancers.
Development
Approach
Lead Optimization
IND-Enabling
Phase I/IB
Monotherapy
Combination with Radiation
Combination with TMZ
High-Grade Glioma & Glioblastoma
High-Grade Glioma & Glioblastoma
Breast, Lung, & Melanoma Cancer
High-Grade Glioma & Glioblastoma
RGNXXX1 - Anti-Infectivity & Anti-Inflammation
Microtubule Targeting Agent
RGNXXX1 is a potent, orally administered, blood-brain barrier penetrant therapy that is being optimized for the treatment of anti-infectivity and neuro-inflammation, such as acute COVID-19 and neuro-inflammatory diseases, respectfully.
IND-Enabling
Development
Approach
Lead Optimization
Phase I/IB
Anti-Infectivity
Anti-Inflammation
Acute COVID-19
Neuro-Inflammatory Diseases
CONTACT US TO
LEARN MORE
3320 N. Campbell Ave Ste 200 | Tucson, AZ 85719 | USA